Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Proliferation of myeloid cells originating from a primitive stem cell.
Biomarker and diagnostic research for myeloid neoplasm has been reported in the published literature.
32 clinical trials registered, 21 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE3, 9 PHASE2, 10 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06710418](https://clinicaltrials.gov/study/NCT06710418) |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 1:26 AM UTC
Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia |
NA |
University of Washington |
RECRUITING |
[NCT07044544](https://clinicaltrials.gov/study/NCT07044544) | Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies | PHASE1 | University of Alabama at Birmingham | RECRUITING |
[NCT05875805](https://clinicaltrials.gov/study/NCT05875805) | A Telehealth Advance Care Planning Intervention | NA | University of Rochester | RECRUITING |
[NCT06621212](https://clinicaltrials.gov/study/NCT06621212) | Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML | PHASE2 | First Affiliated Hospital of Zhejiang University | RECRUITING |
[NCT04501120](https://clinicaltrials.gov/study/NCT04501120) | Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML | PHASE1 | Ascentage Pharma Group Inc. | RECRUITING |
317 publications have been identified in PubMed for myeloid neoplasm. Research spans Case Report / Case Series (25%), Basic Science / Preclinical (24%), and Review / Meta-Analysis (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 68 | 25% |
Laboratory research | 66 | 24% |
Research summaries | 44 | 16% |
Disease patterns and progression | 30 | 11% |
Clinical study results | 25 | 9% |
Testing and diagnosis research | 22 | 8% |
New treatment approaches | 10 | 4% |
Other research | 7 | 3% |
Kajdic A (2026). [PMID: 41616279](https://pubmed.ncbi.nlm.nih.gov/41616279/). *Blood Adv*. [Epidemiology / Natural History]
Fan J (2026). [PMID: 42117712](https://pubmed.ncbi.nlm.nih.gov/42117712/). *Clin Respir J*. [Case Report / Case Series]
Hakkarainen M (2026). [PMID: 41628318](https://pubmed.ncbi.nlm.nih.gov/41628318/). *Blood Adv*. [Clinical Trial Publication]
Chow W (2026). [PMID: 41947786](https://pubmed.ncbi.nlm.nih.gov/41947786/). *Endocr Oncol*. [Case Report / Case Series]
Reiter A (2026). [PMID: 41187902](https://pubmed.ncbi.nlm.nih.gov/41187902/). *The journal of allergy and clinical immunology. In practice*. [Diagnostic / Biomarker]
Zhu Y (2026). [PMID: 41811504](https://pubmed.ncbi.nlm.nih.gov/41811504/). *Virchows Arch*. [Case Report / Case Series]
Rocha LO (2026). [PMID: 42003760](https://pubmed.ncbi.nlm.nih.gov/42003760/). *Pediatr Blood Cancer*. [Case Report / Case Series]
Zhang P (2026). [PMID: 40819104](https://pubmed.ncbi.nlm.nih.gov/40819104/). *Cell Death Differ*. [Basic Science / Preclinical]
Lanino L (2026). [PMID: 41894646](https://pubmed.ncbi.nlm.nih.gov/41894646/). *J Clin Oncol*. [Basic Science / Preclinical]
Chakraborty S (2026). [PMID: 41703028](https://pubmed.ncbi.nlm.nih.gov/41703028/). *Leukemia*. [Basic Science / Preclinical]